While these findings establish the role of MMP-3 and MCP-1 in IRI-induced pulmonary inflammation, our study is the first to demonstrate that apigenin significantly suppresses MCP-1 expression, highlighting its potential therapeutic role in mitigating remote pulmonary inflammation. Here, MMP3 is linked to inflammatory response.